These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 13245235)

  • 1. [Effect of penicillin on immunologic processes in rabbits inoculated with scarlet fever toxin].
    RUDAS I; SURANYI M
    Orv Hetil; 1955 May; 96(20):546-7. PubMed ID: 13245235
    [No Abstract]   [Full Text] [Related]  

  • 2. [Active immunization against scarlet fever. II. Desensitization with streptococcal toxin as a method of detection of scarlet fever toxin in a mixture with antibiotics].
    VOLOVICH NI; PEDENKO AI
    Zh Mikrobiol Epidemiol Immunobiol; 1954 Mar; 3():35. PubMed ID: 13157583
    [No Abstract]   [Full Text] [Related]  

  • 3. [Active immunization against scarlet fever. I. Intranasal desensitization with streptococcal toxin].
    VOLOVICH NI; PEDENKO AI
    Zh Mikrobiol Epidemiol Immunobiol; 1954 Mar; 3():34. PubMed ID: 13157582
    [No Abstract]   [Full Text] [Related]  

  • 4. [Immunogenic properties of formalin-treated preparation of purified scarlatine-streptococcal toxin].
    BESPALOVA MV
    Zh Mikrobiol Epidemiol Immunobiol; 1955 Sep; (9):62. PubMed ID: 13282457
    [No Abstract]   [Full Text] [Related]  

  • 5. Inability of penicillin to neutralize Dick and Schick toxins.
    DOWLING HF; HIRSH HL
    Proc Soc Exp Biol Med; 1946 Oct; 63(1):167-9. PubMed ID: 20274306
    [No Abstract]   [Full Text] [Related]  

  • 6. [Precipitation in gel reaction with scarlet fever toxin].
    PAVLOV PV; AKIMOVA VV
    Zh Mikrobiol Epidemiol Immunobiol; 1960 Oct; 31():39-44. PubMed ID: 13733591
    [No Abstract]   [Full Text] [Related]  

  • 7. [Titration of erythrogenic scarlet fever toxin by means of a quantitative complement fixation].
    TARKHANOVA IO; KONIKOV AP; AKIMOVA VV
    Zh Mikrobiol Epidemiol Immunobiol; 1957 Feb; 28(2):26-32. PubMed ID: 13423804
    [No Abstract]   [Full Text] [Related]  

  • 8. [Study of the immunological and epidemiological activity of purified sorbed scarlet fever toxin].
    MITEL'MAN SL
    Zh Mikrobiol Epidemiol Immunobiol; 1960 Aug; 31():70-5. PubMed ID: 13771373
    [No Abstract]   [Full Text] [Related]  

  • 9. [A comparative experimental study of 3 depot preparations of scarlet fever erythrogenic toxin].
    KUSHKO IV; AKIMOVA VV
    Zh Mikrobiol Epidemiol Immunobiol; 1960 Aug; 31():51-4. PubMed ID: 13755376
    [No Abstract]   [Full Text] [Related]  

  • 10. THE PYROGENIC EFFECT OF SCARLET FEVER TOXIN. I. NEUTRALIZATION WITH ANTITOXIN; THE NATURE OF TOLERANCE.
    SCHUH V
    Folia Microbiol (Praha); 1965 May; 10():156-62. PubMed ID: 14344773
    [No Abstract]   [Full Text] [Related]  

  • 11. Antigens in scarlatinal erythrogenic toxin demonstrable by the Oudin technic.
    JENNINGS RK
    J Immunol; 1953 Feb; 70(2):181-6. PubMed ID: 13035104
    [No Abstract]   [Full Text] [Related]  

  • 12. Host-parasite factors in group A streptococcal infections. Pyrogenic and other effects of immunologic distinct exotoxins related to scarlet fever toxins.
    WATSON DW
    J Exp Med; 1960 Feb; 111(2):255-84. PubMed ID: 13783427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Purified adsorbed scarlet fever toxin. III. Result of active immunization against scarlet fever with purified adsorbed scarlet fever toxin].
    PAVLOV PV; MITEL'MAN SL; AKIMOVA VV
    Zh Mikrobiol Epidemiol Immunobiol; 1958 Sep; 29(9):11-5. PubMed ID: 13605085
    [No Abstract]   [Full Text] [Related]  

  • 14. [Studies on the purification and concentration of Dick toxin].
    MESROBEANU L; BALDOVIN C; MITRICA N; SARAGEA A; GRITAENCO V
    Stud Cercet Inframicrobiol; 1955; 6(3-4):523-32. PubMed ID: 13324597
    [No Abstract]   [Full Text] [Related]  

  • 15. Observations on the effectiveness of various scarlet fever antigens used in combination with other antigens in multiple antigen preparations.
    VOLK VK; TOP FH; BUNNEY WE
    Am J Public Health Nations Health; 1953 Jul; 43(7):833-9. PubMed ID: 13065535
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunization against scarlet fever with tannic acid-precipitated erythrogenic toxin.
    SCHAEFFER M; TOOMEY JA
    Pediatrics; 1948 Feb; 1(2):188-94. PubMed ID: 18908838
    [No Abstract]   [Full Text] [Related]  

  • 17. [Scarlet fever and second scarlet fever infection today].
    Deutsch J; Scholz HJ
    Dtsch Med Wochenschr; 1967 Apr; 92(17):797-804. PubMed ID: 6024544
    [No Abstract]   [Full Text] [Related]  

  • 18. [STUDY OF THE EPIDEMIOLOGICAL EFFECTIVENESS OF PURIFIED SORBED SCARLET FEVER TOXIN].
    MITELMAN SL
    Zh Mikrobiol Epidemiol Immunobiol; 1963 Sep; 40():61-4. PubMed ID: 14119969
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effectiveness of intracutaneous vaccination against scarlet fever with purified concentration toxin].
    FILOSOVA TG; SHEKHTER AB; GLUSHAN EF
    Zh Mikrobiol Epidemiol Immunobiol; 1954 Mar; 3():36. PubMed ID: 13157584
    [No Abstract]   [Full Text] [Related]  

  • 20. [Antistreptolysin titer and immunity to diseases in scarlet fever].
    WIESENER H; STUCK B
    Klin Wochenschr; 1955 Sep; 33(35-36):845-8. PubMed ID: 13264553
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.